Seres Therapeutics, Inc. Liabilities Assumed
Seres Therapeutics, Inc. (MCRB) reported Liabilities Assumed of $780.00 thousand for the 6-month period ending 2015-06-30, per its 10-Q filed 2016-08-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2017-03-16
- Seres Therapeutics, Inc. liabilities assumed for the quarter ending 2015-06-30 was $618.00K.
- Seres Therapeutics, Inc. liabilities assumed for the quarter ending 2015-03-31 was $162.00K.
- Seres Therapeutics, Inc. liabilities assumed for the quarter ending 2014-12-31 was $766.00K.
- Seres Therapeutics, Inc. liabilities assumed for fiscal 2014 was $863.00K.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 6 month | Liabilities Assumed 9 month | Liabilities Assumed 12 month |
|---|---|---|---|---|
| 2015-06-30 | $618.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $780.00K 10-Q · filed 2016-08-11 | $1.55M derived: sum of 3 quarters · filed 2017-03-16 | |
| 2015-03-31 | $162.00K 10-Q · filed 2016-05-16 | $928.00K derived: sum of 2 quarters · filed 2017-03-16 | ||
| 2014-12-31 | $766.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $863.00K 10-K · filed 2017-03-16 | ||
| 2014-09-30 | $97.00K 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |